# AET06 variant 1 is produced correctly

    Code
      res
    Output
                                                                             Placebo            Xanomeline High Dose       Xanomeline Low Dose  
                                                                         F            M            F            M            F            M     
                                                                       (N=53)       (N=33)       (N=40)       (N=44)       (N=50)       (N=34)  
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event       21 (39.6%)   13 (39.4%)   27 (67.5%)   36 (81.8%)   34 (68.0%)   27 (79.4%)
      Overall total number of events                                     51           20           84          108          106           68    
        GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                    
          Total number of patients with at least one adverse event   7 (13.2%)     3 (9.1%)    14 (35.0%)   16 (36.4%)   18 (36.0%)   12 (35.3%)
          Total number of events                                         15           5            37           37           35           36    
            APPLICATION SITE ERYTHEMA                                 2 (3.8%)     1 (3.0%)    5 (12.5%)    10 (22.7%)   5 (10.0%)    7 (20.6%) 
            APPLICATION SITE IRRITATION                               3 (5.7%)        0        5 (12.5%)     4 (9.1%)    6 (12.0%)     3 (8.8%) 
            APPLICATION SITE PRURITUS                                 4 (7.5%)     2 (6.1%)    10 (25.0%)   12 (27.3%)   12 (24.0%)   10 (29.4%)
        SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                  
          Total number of patients with at least one adverse event   12 (22.6%)   7 (21.2%)    12 (30.0%)   22 (50.0%)   21 (42.0%)   14 (41.2%)
          Total number of events                                         26           11           29           57           63           27    
            ERYTHEMA                                                 6 (11.3%)     3 (9.1%)    7 (17.5%)    7 (15.9%)    9 (18.0%)    6 (17.6%) 
            PRURITUS                                                 6 (11.3%)     2 (6.1%)    11 (27.5%)   15 (34.1%)   13 (26.0%)   10 (29.4%)
            RASH                                                      2 (3.8%)     3 (9.1%)     3 (7.5%)    8 (18.2%)    8 (16.0%)    5 (14.7%) 
            SKIN IRRITATION                                           3 (5.7%)        0         1 (2.5%)     4 (9.1%)    5 (10.0%)     1 (2.9%) 
        GASTROINTESTINAL DISORDERS                                                                                                              
          Total number of patients with at least one adverse event    3 (5.7%)     1 (3.0%)    4 (10.0%)    7 (15.9%)     4 (8.0%)     1 (2.9%) 
          Total number of events                                         5            1            10           12           8            1     
            NAUSEA                                                    3 (5.7%)        0        4 (10.0%)     2 (4.5%)     2 (4.0%)     1 (2.9%) 
            VOMITING                                                  2 (3.8%)     1 (3.0%)        0        7 (15.9%)     3 (6.0%)        0     
        NERVOUS SYSTEM DISORDERS                                                                                                                
          Total number of patients with at least one adverse event    4 (7.5%)     3 (9.1%)    4 (10.0%)     2 (4.5%)        0         3 (8.8%) 
          Total number of events                                         5            3            7            2            0            4     
            HEADACHE                                                  4 (7.5%)     3 (9.1%)    4 (10.0%)     2 (4.5%)        0         3 (8.8%) 
        VASCULAR DISORDERS                                                                                                                      
          Total number of patients with at least one adverse event       0            0         1 (2.5%)        0            0            0     
          Total number of events                                         0            0            1            0            0            0     
            WOUND HAEMORRHAGE                                            0            0         1 (2.5%)        0            0            0     

# AET06 variant 3 is produced correctly

    Code
      res
    Output
                                                                                     Placebo                                    Xanomeline High Dose                               Xanomeline Low Dose               
      Body System or Organ Class                                   <18.5   18.5 - 24.9   25 - 29.9       >30        <18.5     18.5 - 24.9   25 - 29.9       >30        <18.5     18.5 - 24.9   25 - 29.9       >30   
        Dictionary-Derived Term                                    (N=3)     (N=57)        (N=20)       (N=6)       (N=2)       (N=42)        (N=28)      (N=12)       (N=3)       (N=43)        (N=27)      (N=10)  
      ———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event       0     18 (31.6%)    13 (65.0%)   3 (50.0%)   1 (50.0%)   30 (71.4%)    24 (85.7%)   8 (66.7%)   2 (66.7%)   29 (67.4%)    21 (77.8%)   8 (80.0%)
      Overall total number of events                                 0         45            21           5           1           89            75          27           6           83            58          25    
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                                                                                         
        Total number of patients with at least one adverse event     0      9 (15.8%)    8 (40.0%)    2 (33.3%)   1 (50.0%)   16 (38.1%)    13 (46.4%)   4 (33.3%)   1 (33.3%)   16 (37.2%)    12 (44.4%)   5 (50.0%)
        Total number of events                                       0         19            14           4           1           36            41           8           2           41            25          21    
        PRURITUS                                                     0      3 (5.3%)     4 (20.0%)    1 (16.7%)       0       11 (26.2%)    12 (42.9%)   3 (25.0%)   1 (33.3%)   11 (25.6%)    8 (29.6%)    3 (30.0%)
        ERYTHEMA                                                     0      4 (7.0%)     4 (20.0%)    1 (16.7%)       0        6 (14.3%)    6 (21.4%)    2 (16.7%)       0        5 (11.6%)    8 (29.6%)    2 (20.0%)
        RASH                                                         0      4 (7.0%)      1 (5.0%)        0           0        7 (16.7%)    4 (14.3%)        0           0        9 (20.9%)    3 (11.1%)    1 (10.0%)
        SKIN IRRITATION                                              0      1 (1.8%)     2 (10.0%)        0       1 (50.0%)    2 (4.8%)      2 (7.1%)        0           0        3 (7.0%)         0        2 (20.0%)
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                                                                                           
        Total number of patients with at least one adverse event     0      7 (12.3%)    2 (10.0%)    1 (16.7%)       0       14 (33.3%)    11 (39.3%)   5 (41.7%)   2 (66.7%)   13 (30.2%)    11 (40.7%)   3 (30.0%)
        Total number of events                                       0         15            4            1           0           32            24          18           4           32            30           4    
        APPLICATION SITE PRURITUS                                    0      3 (5.3%)     2 (10.0%)    1 (16.7%)       0        9 (21.4%)    9 (32.1%)    4 (33.3%)   1 (33.3%)    9 (20.9%)    9 (33.3%)    3 (30.0%)
        APPLICATION SITE ERYTHEMA                                    0      2 (3.5%)      1 (5.0%)        0           0        5 (11.9%)    7 (25.0%)    3 (25.0%)   1 (33.3%)    6 (14.0%)    5 (18.5%)        0    
        APPLICATION SITE IRRITATION                                  0      3 (5.3%)         0            0           0        5 (11.9%)     1 (3.6%)    3 (25.0%)   1 (33.3%)    3 (7.0%)     4 (14.8%)        0    
      GASTROINTESTINAL DISORDERS                                                                                                                                                                                     
        Total number of patients with at least one adverse event     0      3 (5.3%)      1 (5.0%)        0           0        8 (19.0%)    3 (10.7%)        0           0        3 (7.0%)      2 (7.4%)        0    
        Total number of events                                       0          5            1            0           0           18            4            0           0            6            3            0    
        VOMITING                                                     0      2 (3.5%)      1 (5.0%)        0           0        5 (11.9%)     2 (7.1%)        0           0        2 (4.7%)      1 (3.7%)        0    
        NAUSEA                                                       0      3 (5.3%)         0            0           0        5 (11.9%)     1 (3.6%)        0           0        2 (4.7%)      1 (3.7%)        0    
      NERVOUS SYSTEM DISORDERS                                                                                                                                                                                       
        Total number of patients with at least one adverse event     0      5 (8.8%)     2 (10.0%)        0           0        2 (4.8%)     3 (10.7%)    1 (8.3%)        0        3 (7.0%)         0            0    
        Total number of events                                       0          6            2            0           0            2            6            1           0            4            0            0    
        HEADACHE                                                     0      5 (8.8%)     2 (10.0%)        0           0        2 (4.8%)     3 (10.7%)    1 (8.3%)        0        3 (7.0%)         0            0    
      VASCULAR DISORDERS                                                                                                                                                                                             
        Total number of patients with at least one adverse event     0          0            0            0           0        1 (2.4%)         0            0           0            0            0            0    
        Total number of events                                       0          0            0            0           0            1            0            0           0            0            0            0    
        WOUND HAEMORRHAGE                                            0          0            0            0           0        1 (2.4%)         0            0           0            0            0            0    

# AET06 variant 5 is produced correctly

    Code
      res
    Output
                                                                             Placebo            Xanomeline High Dose       Xanomeline Low Dose  
                                                                         F            M            F            M            F            M     
                                                                       (N=53)       (N=33)       (N=40)       (N=44)       (N=50)       (N=34)  
      ——————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one adverse event       21 (39.6%)   13 (39.4%)   27 (67.5%)   36 (81.8%)   34 (68.0%)   27 (79.4%)
      Overall total number of events                                     51           20           84          108          106           68    
      GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS                                                                                      
        Total number of patients with at least one adverse event     7 (13.2%)     3 (9.1%)    14 (35.0%)   16 (36.4%)   18 (36.0%)   12 (35.3%)
        Total number of events                                           15           5            37           37           35           36    
        HLT_0617                                                                                                                                
          Total number of patients with at least one adverse event    2 (3.8%)     1 (3.0%)    5 (12.5%)    10 (22.7%)   5 (10.0%)    7 (20.6%) 
          Total number of events                                         2            1            9            14           8            12    
            APPLICATION SITE ERYTHEMA                                 2 (3.8%)     1 (3.0%)    5 (12.5%)    10 (22.7%)   5 (10.0%)    7 (20.6%) 
        HLT_0317                                                                                                                                
          Total number of patients with at least one adverse event    4 (7.5%)     2 (6.1%)    10 (25.0%)   12 (27.3%)   12 (24.0%)   10 (29.4%)
          Total number of events                                         6            4            19           16           17           16    
            APPLICATION SITE PRURITUS                                 4 (7.5%)     2 (6.1%)    10 (25.0%)   12 (27.3%)   12 (24.0%)   10 (29.4%)
        HLT_0061                                                                                                                                
          Total number of patients with at least one adverse event    3 (5.7%)        0        5 (12.5%)     4 (9.1%)    6 (12.0%)     3 (8.8%) 
          Total number of events                                         7            0            9            7            10           8     
            APPLICATION SITE IRRITATION                               3 (5.7%)        0        5 (12.5%)     4 (9.1%)    6 (12.0%)     3 (8.8%) 
      SKIN AND SUBCUTANEOUS TISSUE DISORDERS                                                                                                    
        Total number of patients with at least one adverse event     12 (22.6%)   7 (21.2%)    12 (30.0%)   22 (50.0%)   21 (42.0%)   14 (41.2%)
        Total number of events                                           26           11           29           57           63           27    
        HLT_0284                                                                                                                                
          Total number of patients with at least one adverse event   6 (11.3%)     3 (9.1%)    7 (17.5%)    7 (15.9%)    9 (18.0%)    6 (17.6%) 
          Total number of events                                         8            5            8            14           16           8     
            ERYTHEMA                                                 6 (11.3%)     3 (9.1%)    7 (17.5%)    7 (15.9%)    9 (18.0%)    6 (17.6%) 
        HLT_0778                                                                                                                                
          Total number of patients with at least one adverse event   6 (11.3%)     2 (6.1%)    11 (27.5%)   15 (34.1%)   13 (26.0%)   10 (29.4%)
          Total number of events                                         9            2            14           24           23           12    
            PRURITUS                                                 6 (11.3%)     2 (6.1%)    11 (27.5%)   15 (34.1%)   13 (26.0%)   10 (29.4%)
        HLT_0583                                                                                                                                
          Total number of patients with at least one adverse event    3 (5.7%)        0         1 (2.5%)     4 (9.1%)    5 (10.0%)     1 (2.9%) 
          Total number of events                                         4            0            2            6            11           2     
            SKIN IRRITATION                                           3 (5.7%)        0         1 (2.5%)     4 (9.1%)    5 (10.0%)     1 (2.9%) 
        HLT_0762                                                                                                                                
          Total number of patients with at least one adverse event    2 (3.8%)     3 (9.1%)     3 (7.5%)    8 (18.2%)    8 (16.0%)    5 (14.7%) 
          Total number of events                                         5            4            5            13           13           5     
            RASH                                                      2 (3.8%)     3 (9.1%)     3 (7.5%)    8 (18.2%)    8 (16.0%)    5 (14.7%) 
      GASTROINTESTINAL DISORDERS                                                                                                                
        Total number of patients with at least one adverse event      3 (5.7%)     1 (3.0%)    4 (10.0%)    7 (15.9%)     4 (8.0%)     1 (2.9%) 
        Total number of events                                           5            1            10           12           8            1     
        HLT_0016                                                                                                                                
          Total number of patients with at least one adverse event    2 (3.8%)     1 (3.0%)        0        7 (15.9%)     3 (6.0%)        0     
          Total number of events                                         2            1            0            9            4            0     
            VOMITING                                                  2 (3.8%)     1 (3.0%)        0        7 (15.9%)     3 (6.0%)        0     
        HLT_0742                                                                                                                                
          Total number of patients with at least one adverse event    3 (5.7%)        0        4 (10.0%)     2 (4.5%)     2 (4.0%)     1 (2.9%) 
          Total number of events                                         3            0            10           3            4            1     
            NAUSEA                                                    3 (5.7%)        0        4 (10.0%)     2 (4.5%)     2 (4.0%)     1 (2.9%) 
      NERVOUS SYSTEM DISORDERS                                                                                                                  
        Total number of patients with at least one adverse event      4 (7.5%)     3 (9.1%)    4 (10.0%)     2 (4.5%)        0         3 (8.8%) 
        Total number of events                                           5            3            7            2            0            4     
        HLT_0064                                                                                                                                
          Total number of patients with at least one adverse event    4 (7.5%)     3 (9.1%)    4 (10.0%)     2 (4.5%)        0         3 (8.8%) 
          Total number of events                                         5            3            7            2            0            4     
            HEADACHE                                                  4 (7.5%)     3 (9.1%)    4 (10.0%)     2 (4.5%)        0         3 (8.8%) 
      VASCULAR DISORDERS                                                                                                                        
        Total number of patients with at least one adverse event         0            0         1 (2.5%)        0            0            0     
        Total number of events                                           0            0            1            0            0            0     
        HLT_0154                                                                                                                                
          Total number of patients with at least one adverse event       0            0         1 (2.5%)        0            0            0     
          Total number of events                                         0            0            1            0            0            0     
            WOUND HAEMORRHAGE                                            0            0         1 (2.5%)        0            0            0     

